Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Recruiting

Phase 2

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Sponsor:

Kyowa Kirin Co., Ltd.

Code:

NCT06116916

Conditions

Diabetic Macular Edema (DME)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KHK4951

Aflibercept Injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Kyowa Kirin Co., Ltd. on 2025-04-29.